Track Achilles Therapeutics Plc's other current assets ($3.8M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Achilles Therapeutics Plc (ACHL) currently reports a other current assets of $3.8M as of September 2024. That compares with $15M in the prior-year period — down 75.3% year over year. Use the charts on this page to explore Achilles Therapeutics Plc's other current assets history and peer comparisons.
Achilles Therapeutics Plc's other current assets decreased from $15M to $3.8M — a 75.3% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Achilles Therapeutics Plc reported $3.8M in other current assets as of September 2024. That compares with $15M in the prior-year period — down 75.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current assets of $3.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Achilles Therapeutics Plc, and consider following ACHL for alerts when major investors trade the stock.
Achilles Therapeutics Plc is classified in the Healthcare sector. On other current assets, it currently shows $3.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACHL with unrelated industries.